AKUMS
Invest with MTF
Invest Now
Invest in Akums Drugs & Pharmaceuticals with 3.22X leverage
Performance
- Low
- ₹415
- High
- ₹423
- 52 Week Low
- ₹405
- 52 Week High
- ₹678
- Open Price₹416
- Previous Close₹418
- Volume102,793
Investment Returns
- Over 1 Month -7%
- Over 3 Month -9.57%
- Over 6 Month -25.27%
- Over 1 Year -32.47%
Smart Investing Starts Here Start SIP with Akums Drugs & Pharmaceuticals for Steady Growth!
Akums Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 20.9
- PEG Ratio
- 1.5
- Market Cap Cr
- 6,636
- P/B Ratio
- Average True Range
- 11.39
- EPS
- 19.54
- Dividend Yield
- 0
- MACD Signal
- -8.56
- RSI
- 42
- MFI
- 35.87
Akums Drugs & Pharmaceuticals Financials
Akums Drugs & Pharmaceuticals Technicals
EMA & SMA
Current Price
₹421.60
+
3.25
(0.78%)
- Bearish Moving Average 14
- Bullish Moving Average 2
- 20 Day
- ₹427.80
- 50 Day
- ₹443.35
- 100 Day
- ₹466.80
- 200 Day
- ₹523.21
Resistance and Support
419.97
- R3 433.08
- R2 428.17
- R1 424.88
- S1 416.68
- S2 411.77
- S3 408.48
Akums Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-13 | Quarterly Results | |
| 2025-08-08 | Quarterly Results | |
| 2025-05-26 | Audited Results | |
| 2025-02-06 | Quarterly Results | |
| 2024-11-09 | Quarterly Results |
Akums Drugs & Pharmaceuticals F&O
About Akums Drugs & Pharmaceuticals
- NSE Symbol
- AKUMS
- BSE Symbol
- 544222
- Managing Director
- Mr. Sanjeev Jain
- ISIN
- INE09XN01023
Similar Stocks to Akums Drugs & Pharmaceuticals
Akums Drugs & Pharmaceuticals FAQs
Akums Drugs & Pharmaceuticals share price is ₹421 As on 09 December, 2025 | 19:53
The Market Cap of Akums Drugs & Pharmaceuticals is ₹6635.7 Cr As on 09 December, 2025 | 19:53
The P/E ratio of Akums Drugs & Pharmaceuticals is 20.9 As on 09 December, 2025 | 19:53
The PB ratio of Akums Drugs & Pharmaceuticals is 2.2 As on 09 December, 2025 | 19:53
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.